Clinical Trials Directory

Trials / Completed

CompletedNCT04645888

Articaine and Bupivacaine in Impacted Tooth Surgery

Evaluation of the Effects of Articaine and Bupivacaine in Impacted Third Molar Tooth Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
25 (actual)
Sponsor
Kocaeli University · Academic / Other
Sex
All
Age
18 Years – 25 Years
Healthy volunteers
Accepted

Summary

Articaine is a common local anesthetic used in oral surgery and belongs to the amide group of it has fast onset with little side effects. Bupivacaine is preferred in prolonged surgical procedures with its long duration of action and residual analgesic effect. The aim of this study was to evaluate the anesthetic, analgesic, hemodynamic effects of 4% articaine and 0.5% bupivacaine in extraction of impacted mandibular third molar teeth in intraoperative and postoperative periods. Hemodynamic parameters, onset of anesthetic action, total amount, intraoperative comfort, intraoperative bleeding, duration of postoperative anesthesia and analgesia, rescue analgesic use, maximum incisal opening and postoperative pain at 6th, 12th, 24th, 48th and 72th hours and 7th day using a visual analogue scale be evaluated.

Conditions

Interventions

TypeNameDescription
PROCEDUREImpacted tooth surgerySurgical extraction of İmpacted tooth

Timeline

Start date
2018-12-01
Primary completion
2019-02-25
Completion
2019-02-25
First posted
2020-11-27
Last updated
2020-11-27

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04645888. Inclusion in this directory is not an endorsement.